Emerging Technologies
Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.
AI algorithms will inform treatment decisions by recognising patterns of data from past treatments.
The new system can be used with Apple iPhones and lets users check their glucose without needing a reader.
HIMSS21 Digital
In an upcoming HIMSS21 Global Conference Digital Session, Google Cloud CEO Thomas Kurian will discuss where healthcare tech will go from here.
The app was able to make suggestions about exercises for patients with osteoarthritis of the knee or hip.
The company hopes this study will be a stepping stone towards regulatory approval of its product.
The investment round was led by Felix Capital and will enable the company to scale current offerings and expand into new areas.
Luxsonic's virtual reality suite, the SieVRt, landed clearance from Health Canada in order to be used in diagnostic radiology.
The online tool provides a COVID-19 patient's risk score, expected time to death and survival probability curve based on 15 health variables.
The new tool must be prescribed by a doctor, but is not intended to replace medications.